The Overwatch Community came together to raise $12.7 million for the Breast Cancer Research Foundation by purchasing the Pink Mercy skin that was available May 8 until May 21. I bought it twice, and 100% of the proceeds from Pink Mercy went directly to the BCRF. Great job everyone!
On May 8, when players opened up Overwatch they were met with a notice that talked about this brand new Pink Mercy skin, and that the proceeds would go to breast cancer research. The skin sold for $15 USD. The skin, for Overwatch‘s premier healer was adorn with pink ribbons and pink armor. Her blonde hair tied into pig tails with pink ribbons holding them, with her staff having similar ribbons wrapped around it. Even her blaster shoots out pink bullets! It’s an amazing skin, and I use it every time.
The Pink Mercy skin was only available for purchase between May 8 and May 21. Pink Mercy will not be obtainable from loot boxes, and who knows if it will be available again in the future. As well as the skin, Blizzard also sold limited time t-shirts with those proceeds going towards the BCRF as well.
Some Overwatch streamers even got in on the donating. Fourteen streamers partnered with Blizzard and for one day, and all donations received also went to the BCRF. These charity streams raised $130,000 on their own. The grand total down to the last dollar was $12,703,828.87. This was the biggest donation to the Breast Cancer Research Foundation by a corporate partner within a year ever in its 25-year history! Blizzard held a check presentation ceremony on June 25, 2018 at Blizzard headquarters for BCRF leadership.
It feels great to be apart of the community that made this large of a donation happen. Like I said, I bought this skin twice, and if I still had Xbox Live I would have bought it a third time. If you wanted to donate or find out how you can volunteer to the Breast Cancer Research Foundation you can do so by visiting their website.
How do you feel about this charitable donation by the Overwatch community and Blizzard? Let us know in the comments.